Close Menu

NEW YORK – On Quest Diagnostics' recent Q2 earnings call, company Chairman, President, and CEO Steve Rusckowski observed that since the SARS-CoV-2 pandemic arrived in the US this winter, microbiology has gone from something of a "backwater" within the laboratory "to front and center."

This has occasioned some growing pains, not least of all around staffing, Rusckowski said, noting that with regard to SARS-CoV-2 testing, the company has run into "capacity limits around the people and those that are trained adequately to deliver on this."

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.